Jardiance® (Empagliflozin Tablets) – 10 mg | 25 mg

Jardiance® (Empagliflozin Tablets) is an oral antidiabetic medicine belonging to the SGLT-2 inhibitor class, used for the management of type 2 diabetes mellitus. It helps lower blood glucose levels by promoting glucose excretion through urine and supports overall metabolic control.

Jardiance is widely prescribed due to its proven benefits in glycemic control, weight management, and cardiovascular risk reduction in eligible patients. It is commonly used as monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin.

Available strengths include 10 mg and 25 mg, allowing dose flexibility based on patient needs and clinical response.

Medicina Overseas supplies Jardiance® tablets for international markets, supporting pharmacies, hospitals, wholesalers, and importers with bulk quantities, export-grade packaging, and documentation on enquiry.

⚠️ Prescription medicine. Use only under medical supervision.

✅ KEY USES (OPTIONAL – IMPROVES CONVERSION)

• Management of type 2 diabetes

• Helps reduce blood sugar levels

• Supports weight control

• Cardiovascular benefits in eligible patients

• Once-daily oral therapy